<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Peptio</title><description>Structured, source-linked summaries of what peer-reviewed research actually says about individual peptides, and where the evidence runs out.</description><link>https://peptioresearch.com/</link><language>en-GB</language><item><title>BPC-157 human studies: what has been measured in people</title><link>https://peptioresearch.com/articles/bpc-157-human-evidence/</link><guid isPermaLink="true">https://peptioresearch.com/articles/bpc-157-human-evidence/</guid><description>Every published human study of BPC-157, what each one measured, and why the total is 31 people in uncontrolled reports plus two conference abstracts.</description><pubDate>Fri, 02 Oct 2026 00:00:00 GMT</pubDate></item><item><title>Is BPC-157 legal? Regulatory status and what is documented</title><link>https://peptioresearch.com/articles/bpc-157-safety-and-legal-status/</link><guid isPermaLink="true">https://peptioresearch.com/articles/bpc-157-safety-and-legal-status/</guid><description>BPC-157 is not an approved medicine anywhere, is prohibited in sport at all times, and is widely sold. What regulators have actually published, and when.</description><pubDate>Fri, 02 Oct 2026 00:00:00 GMT</pubDate></item><item><title>BPC-157 vs TB-500: what the evidence actually separates</title><link>https://peptioresearch.com/articles/bpc-157-vs-tb-500/</link><guid isPermaLink="true">https://peptioresearch.com/articles/bpc-157-vs-tb-500/</guid><description>Two peptides sold for the same thing, compared on what has been measured: one head-to-head rat study, no human efficacy trial, and one regulatory difference.</description><pubDate>Fri, 02 Oct 2026 00:00:00 GMT</pubDate></item></channel></rss>